Stereotactic Radiosurgery Dose Escalation for Brain Metastases

Abroad (travel likely)RecruitingPHASE1

Conditions

Brain Metastases

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Huntsman Cancer Institute, Salt Lake City, Utah, United States
Contact: Study coordinator (David Ostler) · David.Ostler@hci.utah.edu · 801-587-4429
Contact: Principal Investigator (Lindsay Burt, MD)

Study leads

Lindsay Burt, MD
Principal Investigator
Huntsman Cancer Institute/ University of Utah

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Role of Hyperpolarized 13C-Pyruvate MR Spectroscopy in Patients With Intracranial Metastasis Treated With (SRS)

Brain Metastases

Abroad (travel likely)RecruitingPHASE1

Toronto, Canada

Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance

Brain Metastases · Nonsmall Cell Lung Cancer Stage III

Abroad (travel likely)RecruitingPHASE2

Winston-Salem, United States

Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases

Melanoma · Brain Metastases

Abroad (travel likely)RecruitingPHASE2

Palo Alto, United States

Novel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain Metastases

Brain Metastases From Non-small Cell Lung Cancer (NSCLC) · Brain Metastases From Melanoma · Brain Metastases From Breast Cancer

Abroad (travel likely)Recruiting

Amsterdam, Netherlands